ECSP109771A - CXCR4 CYCLIC PEPTIDE ANTAGONISTS - Google Patents

CXCR4 CYCLIC PEPTIDE ANTAGONISTS

Info

Publication number
ECSP109771A
ECSP109771A EC2010009771A ECSP109771A ECSP109771A EC SP109771 A ECSP109771 A EC SP109771A EC 2010009771 A EC2010009771 A EC 2010009771A EC SP109771 A ECSP109771 A EC SP109771A EC SP109771 A ECSP109771 A EC SP109771A
Authority
EC
Ecuador
Prior art keywords
cxcr4
cyclic peptide
peptide antagonists
antagonists
lactated
Prior art date
Application number
EC2010009771A
Other languages
Spanish (es)
Inventor
Wayne David Kohn
Liang Zeng Yan
Sheng-Bin Peng
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ECSP109771A publication Critical patent/ECSP109771A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se proporcionan antagonistas CXCR4 de péptidos ciclizados por lactamas útiles en el tratamiento de cánceres, artritis reumática, fibrosis pulmonar, e infección por VIH.CXCR4 antagonists of lactated cyclic peptides useful in the treatment of cancers, rheumatic arthritis, pulmonary fibrosis, and HIV infection are provided.

EC2010009771A 2007-05-30 2010-11-27 CXCR4 CYCLIC PEPTIDE ANTAGONISTS ECSP109771A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94080207P 2007-05-30 2007-05-30

Publications (1)

Publication Number Publication Date
ECSP109771A true ECSP109771A (en) 2011-02-26

Family

ID=42263422

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010009771A ECSP109771A (en) 2007-05-30 2010-11-27 CXCR4 CYCLIC PEPTIDE ANTAGONISTS

Country Status (4)

Country Link
EC (1) ECSP109771A (en)
ES (1) ES2367941T3 (en)
SI (1) SI2160221T1 (en)
UA (1) UA99458C2 (en)

Also Published As

Publication number Publication date
UA99458C2 (en) 2012-08-27
SI2160221T1 (en) 2011-11-30
ES2367941T3 (en) 2011-11-11

Similar Documents

Publication Publication Date Title
CR11105A (en) CXCR4 CYCLE PEPTIDE ANTAGONISTS
CL2008001855A1 (en) Boron-derived condensed cyclic compounds; pharmaceutical composition; and use in the treatment and / or prevention of an infectious disease.
PE20120501A1 (en) L-ASPARAGINASE TREATED WITH PEG
PE20140382A1 (en) IL-2 DERIVED POLYPEPTIDES WITH AGONIST ACTIVITY FOR CANCER THERAPY AND CHRONIC INFECTIONS
CY1113770T1 (en) CIRCULAR Anti-microbial Peptides
CL2012001405A1 (en) Spiroindolinone-pyrrolidine derived compounds; obtaining process; pharmaceutical composition; and use in the treatment or prophylaxis of cancer.
BR112012017345A2 (en) "pgl compositions and methods for increased production of isoprene and other products with 6-phosphoglycololactonase (pgl)"
BR112015027321A2 (en) compositions and methods
BRPI0809583A2 (en) modified fgf-21 polypeptides and their uses
EA201001628A1 (en) MODIFIED POLYPEPTIDES OF FACTOR VII AND THEIR APPLICATION
MX2019008549A (en) Bone-targeting antibodies.
DK2190473T3 (en) PEPTID WITH REDUCED DIMERING
GT201300131A (en) METHODS OF TREATMENT OF DISORDERS ASSOCIATED WITH FGF21
MX364611B (en) Amine functional polyamides.
CL2013000018A1 (en) Compounds derived from indolizine, their preparation procedure; pharmaceutical composition; and use in the treatment of cancer, among others.
MA32349B1 (en) ANTAGONISTS OF THE HEDGEHOG PATHWAY BASED ON DISUBSTITUTED PHTALAZINES
CY1113869T1 (en) LYophilized VWF Recombinant Formulations
DE602008002693D1 (en) VACCINE PEPTIDE COMBINATIONS AGAINST CATERING ALLERGY
CL2009000119A1 (en) Compounds derived from substituted amino-benzimidazoles; pharmaceutical composition; and its use in the treatment of Alzheimer's.
CR20110202A (en) ANTAGONISTS OF THE VIA HEDGEHOG OF FTALAZINA DISUSTITUIDA
CY1121083T1 (en) ANTIMICROBIAL PEPTIDE AND ITS USES
MX2009013682A (en) Hydrolysable polymeric fmoc-linker.
CL2012001757A1 (en) 8-hydroxyquinoline-7-carboxamide derived compounds; pharmaceutical composition; and its use in the treatment of fungal infections.
MX2007004025A (en) USE OF NORDIHYDROGUAIARETIC ACID DERIVATIVES IN THE TREATMENT OF CANCER AND MICROBIAL AND VIRAL INFECTIONS RESISTANT TO FARMACOS._.
CY1118967T1 (en) HIGH-DOSE BIOTINE PHARMACEUTICAL COMPOSITIONS